Literature DB >> 15564047

The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases.

Christopher A Ross1, Cecile M Pickart.   

Abstract

During the past decade, it has become apparent that a set of ostensibly unrelated neurodegenerative diseases, including Parkinson's disease and Huntington's disease, shares striking molecular and cell biology commonalities. Each of the diseases involves protein misfolding and aggregation, resulting in inclusion bodies and other aggregates within cells. These aggregates often contain ubiquitin, which is the signal for proteolysis by the 26S proteasome, and chaperone proteins that are involved in the refolding of misfolded proteins. The link between the ubiquitin-proteasome system and neurodegeneration has been strengthened by the identification of disease-causing mutations in genes coding for several ubiquitin-proteasome pathway proteins in Parkinson's disease. However, the exact molecular connections between these systems and pathogenesis remain uncertain and controversial. In this article, we summarize the state of current knowledge, focusing on important unresolved questions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15564047     DOI: 10.1016/j.tcb.2004.10.006

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  77 in total

1.  The yeast E4 ubiquitin ligase Ufd2 interacts with the ubiquitin-like domains of Rad23 and Dsk2 via a novel and distinct ubiquitin-like binding domain.

Authors:  Petra Hänzelmann; Julian Stingele; Kay Hofmann; Hermann Schindelin; Shahri Raasi
Journal:  J Biol Chem       Date:  2010-04-28       Impact factor: 5.157

Review 2.  Oxidative stress and the ubiquitin proteolytic system in age-related macular degeneration.

Authors:  Scott M Plafker
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

Review 3.  Redox regulation of protein misfolding, mitochondrial dysfunction, synaptic damage, and cell death in neurodegenerative diseases.

Authors:  Tomohiro Nakamura; Dong-Hyung Cho; Stuart A Lipton
Journal:  Exp Neurol       Date:  2012-07-05       Impact factor: 5.330

Review 4.  Redox reactions induced by nitrosative stress mediate protein misfolding and mitochondrial dysfunction in neurodegenerative diseases.

Authors:  Zezong Gu; Tomohiro Nakamura; Stuart A Lipton
Journal:  Mol Neurobiol       Date:  2010-03-25       Impact factor: 5.590

5.  The triage of damaged proteins: degradation by the ubiquitin-proteasome pathway or repair by molecular chaperones.

Authors:  Carla Marques; Weimin Guo; Paulo Pereira; Allen Taylor; Cam Patterson; Paul C Evans; Fu Shang
Journal:  FASEB J       Date:  2006-02-09       Impact factor: 5.191

6.  Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington's and Parkinson's diseases.

Authors:  Ruth A Bodner; Tiago Fleming Outeiro; Stephen Altmann; Michele M Maxwell; Stephanie H Cho; Bradley T Hyman; Pamela J McLean; Anne B Young; David E Housman; Aleksey G Kazantsev
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-06       Impact factor: 11.205

Review 7.  Mechanisms of selective autophagy and mitophagy: Implications for neurodegenerative diseases.

Authors:  Charleen T Chu
Journal:  Neurobiol Dis       Date:  2018-07-17       Impact factor: 5.996

Review 8.  How Studies of the Serotonin System in Macaque Models of Menopause Relate to Alzheimer's Disease1.

Authors:  Cynthia L Bethea; Arubala P Reddy; Fernanda Lima Christian
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

9.  Aggregates assembled from overexpression of wild-type alpha-synuclein are not toxic to human neuronal cells.

Authors:  Li-Wen Ko; Hwai-Hwa C Ko; Wen-Lang Lin; Jayanranyan G Kulathingal; Shu-Hui C Yen
Journal:  J Neuropathol Exp Neurol       Date:  2008-11       Impact factor: 3.685

10.  Dynein light chain 1 is required for autophagy, protein clearance, and cell death in Drosophila.

Authors:  Yakup Batlevi; Damali N Martin; Udai Bhan Pandey; Claudio R Simon; Christine M Powers; J Paul Taylor; Eric H Baehrecke
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.